N@N

DIAGNOCURE ANNOUNCES THIRD QUARTER 2010 RESULTS

^{Published on 2010-09-13 13:15:15 - Market Wire}
 

 ------------------------------------------------------------------------- For the Third Quarter Ended July 31 ------------------------------------------------------------------------- 2010 2009 ------------------------------------------------------------------------- $ $ ------------------------------------------------------------------------- Sales 8,868 24,782 ------------------------------------------------------------------------- Revenue under research and license agreement 308,720 259,454 ------------------------------------------------------------------------- Interest 38,410 112,232 ------------------------------------------------------------------------- Total revenues 355,998 396,468 ------------------------------------------------------------------------- Cost of sales 4,253 16,551 ------------------------------------------------------------------------- Gross margin 351,745 379,917 ------------------------------------------------------------------------- Operating expenses (before stock-based compensation and loss (gain on foreign exchange) 1,917,576 3,822,025 ------------------------------------------------------------------------- Net loss (before stock-based compensation) (1,565,831) (3,442,108) ------------------------------------------------------------------------- Stock-based compensation 120,516 141,177 ------------------------------------------------------------------------- Loss (gain) on foreign exchange (35,754) 479,588 ------------------------------------------------------------------------- Net loss before income taxes (1,650,593) (4,062,873) ------------------------------------------------------------------------- Future income taxes - 28,509 ------------------------------------------------------------------------- Net loss (1,650,593) (4,034,364) ------------------------------------------------------------------------- Basic and diluted loss per share (0.04) (0.09) ------------------------------------------------------------------------- Weighted average number of common shares outstanding 42,976,140 42,849,475 ------------------------------------------------------------------------- 

 ------------------------------------------------------------------------- As of July 31 ------------------------------------------------------------------------- 2010 2009 ------------------------------------------------------------------------- $ $ ------------------------------------------------------------------------- Cash, cash equivalents, temporary and long-term investments 8,182,119 17,249,422 ------------------------------------------------------------------------- Total assets 18,492,733 29,340,753 ------------------------------------------------------------------------- Shareholders' equity 15,896,356 25,842,928 -------------------------------------------------------------------------